$97.35 1.19 (1.21%)
13:25 EDT NKE Stock Quote Delayed 30 Minutes
Previous Close $98.54
Market Cap 124.87B
PE Ratio 90.14
Volume (Avg. Vol.) 1.55M
Day's Range 97.22 - 98.23
52-Week Range 60.00 - 105.62
Dividend & Yield 0.80 (0.82%)
NKE Stock Predictions, Articles, and NIKE News
- From InvestorPlace
- From the Web
Disney, McDonald's and Nike are three stocks for beginners that are sure to help you avoid obvious mistakes. Own them for the long term.
Strong e-commerce sales and the popularity of comfortable clothing for working from home have helped the recovery in Nike stock.
Nike has set trends and received huge demand for decades, so it's not surprising Nike stock is a winner now. Here's how to profit.
Nike stock has recovered and is probably fully priced here. It sports a high P/E ratio, despite earnings that will double over the next 2 years.
Sports stocks have been among 2020's biggest losers as TV and gate revenues have collapsed. But these 10 could be winners as sports return.
Nike (NASDAQ:NKE) saw some bullish buying, and if you, like us, have been holding shares, its push higher makes this a perfect time to sell covered calls.
Nike posted an earnings loss in the last quarter thanks to the coronavirus, but don't let that dissuade you from buying Nike stock.
As bad as it is, the coronavirus is a short-term problem. It will pass, and when it does, these beaten-up coronavirus stocks to buy will rebound in a big way.
Facebook, Fastly, Nike and Gap were our top stock trades from Friday. So, here's what the charts look like now after a volatile session.
Nike missed on earnings and revenue estimates after a tough quarter. Let's buy Nike stock on a dip, as it's a long-term winner.
Nike (NKE) earnings for the athletic wear company's fiscal fourth quarter of 2020 have NKE stock on the move after markets closed Thursday.
Everything is trending in the right direction for Nike, so investors should stick with the current rally in NKE stock.
With pandemic fears shuttering many economies, most investments have cratered. However, a small group of coronavirus stocks may offer significant upside potential.
Nike's earnings this week are going to be soft thanks to the impact of the coronavirus. But investors should buy any dip in Nike stock.
We recommend taking a middle path by selling covered call against a stock you may already own: Nike, Inc. (NASDAQ:NKE).
Wall Street is in the midst of its biggest rally, ever, and these are the large-cap stocks leading the way.
The consumer spending recovery is underway, and that's great news for these 7 beaten-up apparel stocks to buy on the dip.
The U.S. economy is reopening and consumer spending is rebounding. Here are seven retail stocks to buy to profit from this growing trend.
Summer is kicking off and Americans are returning to the gym. Investors should look to strengthen their portfolios with these fitness stocks.
Brookfield Asset Management (BAM -0.1%) holds the initial closing of its first European core-plus real estate fund with a total equity commitment to date of €725M.The Brookfield European Real Estate Partnership committed in mid-April to its first investment, 42 rue de Paradis, an office building in Paris.Brookfield’s cornerstone investors include a mix of public and private pensions, insurance companies as well as a commitment from Brookfield Asset Management through Brookfield Property Partners (NASDAQ:BPY).“Evolving market dynamics are creating new opportunities and a substantial pipeline in core-plus real estate throughout Europe,” said Zachary Vaughan, head of Europe Real Estate at Brookfield. Robust fundraising helped bolster Brookfield's Q1 results; BAM is scheduled to report Q2 results on Aug.
While the COVID-19 pandemic pressures most of the U.S. real estate sector, including hotels, shopping centers and senior housing communities, it has stoked demand from life sciences companies developing vaccines and treatments for the respiratory infection due the need for laboratory space.Last week, Alexandria Real Estate Equities (ARE +1.2%), the largest life sciences real estate investment trust in America, raised $1.1B via a new share offering which was significantly oversubscribed.Other life sciences-focused real estate players are beefing up their coffers.
From Market News Video
From The Motley Fool
Navellier RatingsPowered by Portfolio Grader